ArticleCurrent protocols2026
Generation of Biparental Bovine Embryos via Haploid Cell Injection (Semi-cloning) for Embryo Production with Predetermined Parental Genomes.
Article in Current protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
This protocol describes a method for generating biparental bovine embryos with predetermined paternal genomes using haploid androgenetic blastomere injection (semi-cloning). The approach enables replacement of sperm at fertilization with pre-genotyped haploid embryonic cells, allowing controlled paternal genome selection prior to embryo reconstruction. The protocol involves producing androgenetic haploid embryos via oocyte enucleation at telophase II, following intracytoplasmic sperm injection (ICSI)-mediated activation. Haploid androgenetic blastomeres are isolated from morula-stage embryos, prepared for micromanipulation, and injected into mature oocytes using a piezo-assisted intracytoplasmic injection system. Reconstructed embryos are subsequently cultured in vitro and may be transferred to recipient females to obtain gestations and offspring with the chosen paternal genome. This method integrates established reproductive technologies, including oocyte selection, in vitro maturation, intracytoplasmic sperm injection, telophase II enucleation, and piezo-assisted cell microinjection, into a unified workflow adapted for bovine embryo production. The protocol provides a platform for sperm genome amplification, genomic characterization of haploid blastomeres prior to use, and reconstruction of embryos with defined paternal genetic composition. Semi-cloned embryos produced using this approach develop to the blastocyst stage in vitro and can establish pregnancies following embryo transfer. This protocol is applicable to researchers in cattle reproductive biotechnology, livestock genetics, and developmental biology, and supports applications in genomic selection, functional genomics, and genetic conservation. © 2026 Wiley Periodicals LLC. Basic Protocol 1: Micropipette production Basic Protocol 2: Micromanipulator setup Basic Protocol 3: Preparation of micromanipulation dishes Basic Protocol 4: Intracytoplasmic sperm injection Basic Protocol 5: Zygote enucleation Basic Protocol 6: Intracytoplasmic haploid cell injection (ICHI).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.